Olutasidenib (FT-2102)

Catalog No. A18789

Olutasidenib is a potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 for the treatment of acute myeloid leukemia.

Technical details

Catalog Num	A18789
M. Wt	354.79
Formula	C18H15ClN4O2
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	1887014-12-1
Synonyms	Olutasidenib; FT-2102; FT 2102; FT2102;
SMILES	N#CC1=CC=C(N[C@H](C2=CC3=C(NC2=O)C=CC(Cl)=C3)C)C(N1C)=O

Biological Activity

Olutasidenib is a potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 for the treatment of acute myeloid leukemia.

Solubility *

In vitro	DMSO	70 mg/mL (197.29 mM)
	Water	Insoluble
	Ethanol	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	28.19 mL	140.93 mL	281.86 mL
0.5 mM	5.64 mL	28.19 mL	56.37 mL
1 mM	2.82 mL	14.09 mL	28.19 mL
5 mM	0.56 mL	2.82 mL	5.64 mL

*The above data is based on the productmolecular weight 354.79. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Adooq Bioscience

Olutasidenib (FT-2102)

Technical details

Biological Activity

Solubility *

Preparing Stock Solutions